Cartesian Therapeutics Email Formats

Biotechnology Research • Ballenger Creek, Maryland, United States • 51-100 Employees

Cartesian Therapeutics Email Formats

Cartesian Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@cartesiantx.com), used 76.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cartesiantx.com	76.6%
{first name}	john@cartesiantx.com	20.3%
{first name}{last name}	johndoe@cartesiantx.com	3.1%

Key Contacts at Cartesian Therapeutics

Cezary Karczewski

Director Of Quality Assurance

Alex Daudier

Director, Fp&A

Hafsa Kamboh

Senior Director Clinical Operations

Charito Buensuceso

Senior Director, R&D Project Management

Yi Zhang

Senior Director, Technology

Megan Leduc

Associate Director, Investor Relations

Kirill Sergueev

Associate Director

Ross Denovellis

Associate Director, Financial Reporting And Technical Accounting

Catherine Vesey

Director, Head Of Hr Operations

Emae Lee-Voritskul

Director Of Accounting

Company overview

Headquarters	7495 New Horizon Way, Frederick, Maryland 21703, US
Phone number	+16179231400
Websites	cartesiantherapeutics.com cartesiantx.com
NAICS	541714
SIC	873
Keywords	Gene Therapy, Oncology, Autoimmune Disease, Immunotherapy, Cancer Research, Cell Therapy, Molecular Biology, Immunology, Autoimmunity, Myasthenia Gravis, Lupus, Multiple Myeloma, Ards, SLE, Mrna, Car-T, Nets, Systemic Lupus Erythematosus
Founded	2016
Employees	51-100
Socials

About Cartesian Therapeutics

Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis and Phase 2 development for systematic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit www.cartesiantherapeutics.com

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Director

Manager

Employees by Department

Cartesian Therapeutics has 34 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Cartesian Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-06-04	9	$2,000,000
2024-08-02	14	$130,000,000

Funding Insights

$132,000,000

Total funding amount

$130,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Cartesian Therapeutics is located in Ballenger Creek, Maryland, US.

You can reach Cartesian Therapeutics at +16179231400.

Cartesian Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Cartesian Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Cartesian Therapeutics has raised a total of $132,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.